Davita - Huntley Dialysis is a medicare approved dialysis facility center in Huntley, Illinois and it has 12 dialysis stations. It is located in Mchenry county at 10370 Haligus Road, Huntley, IL, 60142. You can reach out to the office of Davita - Huntley Dialysis at (847) 669-8145. This dialysis clinic is managed and/or owned by Davita. Davita - Huntley Dialysis has the following ownership type - Profit. It was first certified by medicare in January, 2018. The medicare id for this facility is 142828 and it accepts patients under medicare ESRD program.
Name | Davita - Huntley Dialysis |
---|---|
Location | 10370 Haligus Road, Huntley, Illinois |
No. of Dialysis Stations | 12 |
Medicare ID | 142828 |
Managed By | Davita |
Ownership Type | Profit |
Late Shifts | No |
10370 Haligus Road, Huntley, Illinois, 60142 | |
(847) 669-8145 | |
Not Available |
News Archive
Acorda Therapeutics, Inc. announced data from a preclinical study showed that treatment with Glial Growth Factor 2 (GGF2) improved erectile function in an animal model following a cavernous nerve (CN) injury, a common complication of prostate surgery.
Pathway Genomics™ (www.PATHWAY.com), a privately held, venture-backed company, today launched a new campaign designed to facilitate discussions around consumer genetic testing services. Called ‘DNA Conversation Starters,' Pathway will address a range of topics about genetic testing, further educating members of the media, the genetic testing community, and consumers about the benefits of genetic testing services and the depth of information obtained from Pathway's Genetic Health and Ancestry tests.
Dr. Gregory Swanson and associates from the University of Texas, San Antonio Health Science Center reviews the data for various treatment options in patients with lymph node positive prostate cancer (CaP).
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient's own platelets, allowing the drugs to last longer in the body and attack both primary cancer tumors and the circulating tumor cells that can cause a cancer to metastasize. The work was tested successfully in an animal model.
› Verified 3 days ago
NPI Number | 1275054348 |
Organization Name | Huntley Dialysis |
Doing Business As | Rhodes Dialysis Llc |
Address | 10370 Haligus Rd Ste 100 Huntley, Illinois, 60142 |
Phone Number | (847) 669-8145 |
News Archive
Acorda Therapeutics, Inc. announced data from a preclinical study showed that treatment with Glial Growth Factor 2 (GGF2) improved erectile function in an animal model following a cavernous nerve (CN) injury, a common complication of prostate surgery.
Pathway Genomics™ (www.PATHWAY.com), a privately held, venture-backed company, today launched a new campaign designed to facilitate discussions around consumer genetic testing services. Called ‘DNA Conversation Starters,' Pathway will address a range of topics about genetic testing, further educating members of the media, the genetic testing community, and consumers about the benefits of genetic testing services and the depth of information obtained from Pathway's Genetic Health and Ancestry tests.
Dr. Gregory Swanson and associates from the University of Texas, San Antonio Health Science Center reviews the data for various treatment options in patients with lymph node positive prostate cancer (CaP).
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient's own platelets, allowing the drugs to last longer in the body and attack both primary cancer tumors and the circulating tumor cells that can cause a cancer to metastasize. The work was tested successfully in an animal model.
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.